HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 54 filers reported holding HARPOON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $523,000 | -34.1% | 105,163 | 0.0% | 0.14% | -32.0% |
| Q4 2021 | $794,000 | -4.5% | 105,163 | 0.0% | 0.20% | -9.1% |
| Q3 2021 | $831,000 | -43.0% | 105,163 | 0.0% | 0.22% | -27.9% |
| Q2 2021 | $1,459,000 | -44.9% | 105,163 | -17.0% | 0.30% | -51.5% |
| Q1 2021 | $2,650,000 | +87.4% | 126,663 | +48.8% | 0.63% | +49.4% |
| Q4 2020 | $1,414,000 | -2.2% | 85,119 | 0.0% | 0.42% | -10.4% |
| Q3 2020 | $1,446,000 | +2.3% | 85,119 | 0.0% | 0.47% | +15.2% |
| Q2 2020 | $1,413,000 | -17.3% | 85,119 | -42.3% | 0.41% | -42.8% |
| Q1 2020 | $1,708,000 | – | 147,468 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $2,335,957 | 1.93% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $2,329,753 | 0.97% |
| MPM BioImpact LLC | 3,196,707 | $2,378,350 | 0.62% |
| Lion Point Capital, LP | 169,283 | $125,980 | 0.05% |
| Artal Group S.A. | 1,000,000 | $744 | 0.04% |
| Cormorant Asset Management, LP | 540,600 | $402 | 0.03% |
| KENNEDY CAPITAL MANAGEMENT LLC | 529,934 | $394,377 | 0.01% |
| Orbimed Advisors | 621,218 | $462,310 | 0.01% |
| Tekla Capital Management LLC | 259,910 | $193,425 | 0.01% |
| CM WEALTH ADVISORS LLC | 50,354 | $29 | 0.01% |